The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Urticaria: Collegium Internationale Allergologicum (CIA) Update 2020
Open accessAbstract
This update on chronic urticaria (CU) focuses on the prevalence and pathogenesis of chronic spontaneous urticaria (CSU), the expanding spectrum of patient-reported outcome measures (PROMs) for assessing CU disease activity, impact, and control, as well as future treatment options for CU. This update is needed, as several recently reported findings have led to significant advances in these areas. Some of these key discoveries were first presented at past meetings of the Collegium Internationale Allergologicum (CIA). New evidence shows that the prevalence of CSU is geographically heterogeneous, high in all age groups, and increasing. Several recent reports have helped to better characterize two endotypes of CSU: type I autoimmune (or autoallergic) CSU, driven by IgE to autoallergens, and type IIb autoimmune CSU, which is due to mast cell (MC)-targeted autoantibodies. The aim of treatment in CU is complete disease control with absence of signs and symptoms as well as normalization of quality of life (QoL). This is best monitored by the use of an expanding set of PROMs, to which the Angioedema Control Test, the Cholinergic Urticaria Quality of Life Questionnaire, and the Cholinergic Urticaria Activity Score have recently been added. Current treatment approaches for CU under development include drugs that inhibit the effects of signals that drive MC activation and accumulation, drugs that inhibit intracellular pathways of MC activation and degranulation, and drugs that silence MCs by binding to inhibitory receptors. The understanding, knowledge, and management of CU are rapidly increasing. The aim of this review is to provide physicians who treat CU patients with an update on where we stand and where we will go. Many questions and unmet needs remain to be addressed, such as the development of routine diagnostic tests for type I and type IIb autoimmune CSU, the global dissemination and consistent use of PROMs to assess disease activity, impact, and control, and the development of more effective and well-tolerated long-term treatments for all forms of CU.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fricke, J., Ávila, G., Keller, T., Weller, K., Lau, S., Maurer, M., Zuberbier, T., & Keil, T. (2020) · Allergy · doi:10.1111/all.14037 · Cited by 465
Self-citationHow to assess disease activity in patients with chronic urticaria?
Młynek, A., Zalewska‐Janowska, A., Martus, P., Staubach, P., Zuberbier, T., & Maurer, M. (2008) · Allergy · doi:10.1111/j.1398-9995.2008.01726.x · Cited by 385
Self-citationStaubach, P., Metz, M., Chapman‐Rothe, N., Sieder, C., Bräutigam, M., Canvin, J., & Maurer, M. (2016) · Allergy · doi:10.1111/all.12870 · Cited by 130
Self-citationPsychiatric comorbidity in chronic urticaria patients: a systematic review and meta-analysis
Konstantinou, G. N., & Konstantinou, G. N. (2019) · Clinical and Translational Allergy · doi:10.1186/s13601-019-0278-3 · Cited by 110
Staubach, P., Metz, M., Chapman‐Rothe, N., Sieder, C., Bräutigam, M., Maurer, M., & Weller, K. (2018) · Allergy · doi:10.1111/all.13339 · Cited by 65
Self-citation
Cited by
Zuberbier, T., Abdul Latiff, A. H., Abuzakouk, M., Aquilina, S., Asero, R., Baker, D., Ballmer‐Weber, B., Bangert, C., Ben‐Shoshan, M., Bernstein, J. A., et al. (2022) · Allergy · doi:10.1111/all.15090 · Cited by 1,263
Self-citationAutoimmune chronic spontaneous urticaria
Kolkhir, P., Muñoz, M., Asero, R., Ferrer, M., Kocatürk, E., Metz, M., Xiang, Y.-K., & Maurer, M. (2022) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2022.04.010 · Cited by 301
Self-citationThe ingenious mast cell: contemporary insights into mast cell behavior and function
Dahlin, J. S., Maurer, M., Metcalfe, D. D., Pejler, G., Sagi‐Eisenberg, R., & Nilsson, G. (2022) · Allergy · doi:10.1111/all.14881 · Cited by 147
Self-citationPsychiatric comorbidity in chronic urticaria patients: a systematic review and meta-analysis
Konstantinou, G. N., & Konstantinou, G. N. (2019) · Clinical and Translational Allergy · doi:10.1186/s13601-019-0278-3 · Cited by 110
Neisinger, S., Sousa Pinto, B., Ramanauskaite, A., Bousquet, J., Weller, K., Metz, M., Magerl, M., Kocatürk, E., Cherrez‐Ojeda, I., Gimenez‐Arnau, A. M., et al. (2024) · Clinical and Translational Allergy · doi:10.1002/clt2.12328 · Cited by 37
Self-citation
Metadata
- Authors
- Maurer, M., Eyerich, K., Eyerich, S., Ferrer, M., Gutermuth, J., Hartmann, K., Jakob, T., Kapp, A., Kolkhir, P., Larenas-Linnemann, D., Park, H.-S., Pejler, G., Sánchez-Borges, M., Schäkel, K., Simon, D., Simon, H.-U., Weller, K., Zuberbier, T., & Metz, M.
- Venue
- International Archives of Allergy and Immunology
- Publisher
- S. Karger AG
- Published
- 2020
- Volume
- 181
- Issue
- 5
- Pages
- 321-333
- ISSN
- 1018-2438 (ISSN-L)
- 1423-0097
- OpenAlex
- W3013137634
- Cited by
- 180
- References
- 5
- FWCI
- 19.23
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Urticaria: Collegium Internationale Allergologicum (CIA) Update 2020. https://app.cochat.ai/papers/10.1159/000507218
- The paper
- Maurer, M., Eyerich, K., Eyerich, S., Ferrer, M., Gutermuth, J., Hartmann, K., Jakob, T., Kapp, A., Kolkhir, P., Larenas-Linnemann, D., Park, H.-S., Pejler, G., Sánchez-Borges, M., Schäkel, K., Simon, D., Simon, H.-U., Weller, K., Zuberbier, T., & Metz, M. (2020). Urticaria: Collegium Internationale Allergologicum (CIA) Update 2020. International Archives of Allergy and Immunology. https://doi.org/10.1159/000507218
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.